Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1922 of 6351
-
Cord blood plasma could repair thin uterine lining
Disease control CompletedIn the last years, platelet-rich plasma (PRP) has emerged as a promising alternative to treat endometrial pathologies affecting the endometrial lining. Different studies have tried this therapeutic approach in human patient, but results are not conclusive at all. Also, in the las…
Phase 2 • Sponsor: Fundación IVI • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New implant tackles cataracts and glaucoma in one surgery
Disease control CompletedThe goal of this clinical trial is to learn if the SpyGlass Pharma Bimatoprost Implant System / IOL Combination works to treat cataracts and either ocular hypertension or glaucoma. It will also learn about the safety of the Bimatoprost Implant System / IOL Combination. The main q…
Sponsor: SpyGlass Pharma, Inc. • Aim: Disease control
Last updated Jun 26, 2026 14:10 UTC
-
New drug TAK-280 aims to fight advanced cancers that resist standard care
Disease control Stopped earlyThe main aim of this study is to find out the safety, tolerability, and effect of TAK- 280 in participants with unresectable, locally advanced or metastatic cancer who have experienced treatment failure or are intolerant to standard therapies. Participants will be treated with T…
Phase 1/2 • Sponsor: Takeda • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Simple breathing workout speeds recovery after lung transplant
Symptom relief OngoingFollowing lung transplantation (LTX), patients may exhibit respiratory and skeletal muscle weakness that will affect exercise capacity, increase dyspnea and fatigue, limit activities of daily living (ADL) and decrease quality of life. Inspiratory muscle training (IMT) has been e…
Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
A wearable vest that listens to the lungs: a new hope for heart failure?
Knowledge-focused Stopped earlyThis study is meant primarily to assess the deployment of the ADI CPM System in a clinical setting and determine interoperability of the CPM System within existing care pathways for patients with CHF. In this initial study the CPM System will not be used to determine or support c…
Sponsor: Analog Device, Inc. • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
MS treatment gets personal: could tailored infusions be just as effective?
Disease control OngoingRationale: B-cell depleting therapies like ocrelizumab are very effective in the treatment of relapsing remitting multiple sclerosis (RRMS). As B cell repopulation varies extensively between individuals (ranging from 27-175 weeks), using a treatment scheme with a fixed infusion i…
Phase 4 • Sponsor: Amsterdam UMC, location VUmc • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Joint fluid analysis may unlock personalized knee osteoarthritis care
Knowledge-focused CompletedParticipants with grade 3 and 4 knee osteoarthritis will recieve aspiration of synoivial fluid, and then receive either dextrose, hemaotopoietic stem cell, or platelet rich plasma, or no injection. The synovial fluid will be analyzed for changes in components.
Sponsor: Dharma Bioscience • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
New Cloud-Based system could transform diabetes care in hospitals
Disease control CompletedGiven the known serious consequences of uncontrolled blood sugars during hospitalization, this research plans to study an alternative seamlessly integrated continuous glucose monitoring (CGM) system in the hospital to test a dynamic and digitized, team-based approach to glucose m…
Sponsor: Scripps Whittier Diabetes Institute • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug combo shows promise for tough brain cancer
Disease control OngoingBackground: People with primary diffuse large B-cell lymphoma of the central nervous system (CNS) and aggressive B-cell lymphomas with secondary CNS involvement have a poor prognosis. Researchers want to learn if a combination of drugs can help. Objective: To learn if it is sa…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Breathe your way to lower blood pressure? new study tests quick exercise for postmenopausal women
Disease control Recruiting nowHigh blood pressure (BP) is the major modifiable risk factor for cardiovascular diseases (CVD) and related health conditions, particularly among postmenopausal (PM) women. In adults age ≥50 years this risk is primarily driven by above-normal systolic BP (SBP ≥120 mmHg), as diasto…
Sponsor: University of Colorado, Boulder • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New combo therapy targets tough skin cancers
Disease control Recruiting nowThis phase I trial tests the safety and side effects radiotherapy in combination with atezolizumab in treating patients with cutaneous squamous cell cancer that has spread to nearby tissue or lymph nodes (locally advanced) and can be removed from surgery (resectable) or cannot be…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control CompletedThis trial is a phase I/II study, which is designed to evaluate the safety, tolerance, pharmacokinetic characteristics, receptor occupancy (RO), immunogenicity and effectiveness of LBL-019 monotherapy or combined with anti-PD-1 antibody in patients with advanced malignant tumors.
Phase 1/2 • Sponsor: Nanjing Leads Biolabs Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
ERs test $300 quit card to kick smoking habit
Disease control Recruiting nowThe INITIATE Study is a randomized controlled trial that is testing an intervention designed to increase long-term abstinence among tobacco smokers seen in emergency departments (ED) and other high-volume hospital and community ambulatory care settings. The intervention includes …
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Fenugreek extract put to the test as a natural remedy for erectile dysfunction
Symptom relief OngoingThis is a double blind, randomised, placebo-controlled clinical study with a 12-week participation and 3 groups (2 active groups and 1 placebo group) designed to monitor erectile function symptom severity and the effect Testofen may have on improving erectile function, sexual fun…
Phase 3 • Sponsor: RDC Clinical Pty Ltd • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Mind-Controlled therapy aims to quiet voice spasms
Symptom relief Recruiting nowThe researchers will develop and evaluate the use of adaptive closed-loop brain-computer interface therapeutic intervention in laryngeal dystonia.
Sponsor: Kristina Simonyan • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
New screening trial aims to match kids with relapsed leukemia to targeted therapies
Knowledge-focused Recruiting nowThis study aims to use clinical and biological characteristics of acute leukemias to screen for patient eligibility for available pediatric leukemia sub-trials. Testing bone marrow and blood from patients with leukemia that has come back after treatment or is difficult to treat m…
Phase 1/2 • Sponsor: PedAL BCU, LLC • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
Brain pacemaker gets a software upgrade to fight freezing gait
Symptom relief Recruiting nowA Multi-Center, Controlled Study to Evaluate Use of CereGate Therapy to Reduce Freezing of Gait in Participants Diagnosed with Parkinson's Disease.
Sponsor: CereGate Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Gene therapy trial aims to fix enzyme defect in gaucher disease
Disease control CompletedThis study is a first-in-human, open-label, safety, tolerability, and efficacy study in adult patients with Gaucher disease Type 1. The aims are to investigate the safety/tolerability and efficacy of FLT201, and to investigate the relationship of FLT201 dose to augmentation of re…
Phase 1 • Sponsor: Spur Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Experimental combo targets Hard-to-Treat sarcomas
Disease control OngoingThis trial is a two-step Phase I/II study comprising: Part 1: A dose escalation part with the aim to assess the safety of the proposed combination (N= up to 30 patients). In the dose escalation part, eligible patients will be treated with a fixed dose of pazopanib and escalating…
Phase 1/2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New hope for cerebral palsy: drug may tame involuntary movements
Symptom relief CompletedThe primary objective of this study is to evaluate the efficacy of valbenazine versus placebo on improving chorea in pediatric and adult participants who have dyskinesia due to cerebral palsy (DCP) with choreiform movements.
Phase 3 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC